LAWRENCE, Mass., Oct. 28, 2015 /PRNewswire/ -- NxStage Kidney Care today announced the NxStage Kidney Care RV Tour, a trip that aims to educate patients on more flexible in-center dialysis and home dialysis options available to help enhance their quality of life. NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM) invites patients and their care partners to stop by a Kidney Walk or Open House on the RV tour to meet Brad Payne, a NxStage Kidney Care in-center patient, and NxStage patient advocate Harvey Wells, a kidney transplant recipient and former dialysis patient. The NxStage Kidney Care RV Tour dates, times and locations can be found at nxstagekidneycare.com/events.
Payne will dialyze live inside the RV at the National Kidney Foundation's Pittsburgh Kidney Walk on November 1st while Wells will act as his care partner. Payne, who traveled from his hometown of St. Louis to take part in the tour, will also dialyze in-center at the NxStage Kidney Care Pittsburgh clinic Open House on November 2nd to demonstrate how NxStage Kidney Care supports patients interested in traveling.
"Most patients think that dialysis means you are confined to a center near home with a rigid treatment schedule," said Payne. "I'm thrilled to be part of this RV tour to help educate patients about flexible dialysis therapy options that can help others regain control of their lives."
Payne began receiving regular dialysis treatments at the age of 20. After trying various treatment modalities, he began hemodialysis, first at home and later in-center five times a week with the NxStage® System One™ at NxStage Kidney Care St. Louis. The flexible options and scheduling available to him at NxStage Kidney Care has allowed Payne to enjoy an active lifestyle and spend more time with his two sons.
Wells began dialyzing at home with the System One in 2007, and in 2011 he received a second transplant. Quickly after, Wells became a NxStage patient advocate and has been touring the country to share his experiences with home hemodialysis.
NxStage Kidney Care has 14 centers nationwide offering multiple therapies using the NxStage System One, including flexible in-center hemodialysis, home hemodialysis (HHD), home nocturnal hemodialysis, and short-term respite care. The centers also offer peritoneal dialysis (PD), along with personalized training for all home therapies provided.
About NxStage Kidney Care
NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), is innovating a dialysis care model that is intended to support and encourage patient centered care and provide enhanced access to the life-changing benefits of home therapy as well as flexible in-center options. By leveraging NxStage's home leadership and the innovative technology of its System One, NxStage Kidney Care is committed to helping patients take control of their dialysis and to allowing physicians the flexibility to prescribe what is truly best for their patients. For more information, please visit www.nxstagekidneycare.com or call (866) 694-2707.
About NxStage Medical
NxStage Medical Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2015. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Kristen K. Sheppard, Esq.
Tel: (978) 332-5923
SOURCE NxStage Medical, Inc.